Targeting the Uneven Burden of Kidney Disease on Black Americans
New treatments aim for a gene variant causing the illness in people of sub-Saharan African descent. Some experts worry that focus will neglect other factors.
Category: Black People
New treatments aim for a gene variant causing the illness in people of sub-Saharan African descent. Some experts worry that focus will neglect other factors.
New treatments aim for a gene variant causing the illness in people of sub-Saharan African descent. Some experts worry that focus will neglect other factors.
A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work.
Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black Americans.
Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black Americans.
Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black Americans.
Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results?
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
President Biden should choose the next director of the U.S. Patent and Trademark Office carefully.
President Biden should choose the next director of the U.S. Patent and Trademark Office carefully.
President Biden should choose the next director of the U.S. Patent and Trademark Office carefully.
The nonprofit marketing group led a polio vaccine campaign in the 1950s. Now it is working on a $50 million ad blitz to counter concerns about coming treatments.